Literature DB >> 2430957

The isolation, characterization, and comparison of the membrane-associated and soluble folate-binding proteins from human KB cells.

P C Elwood, M A Kane, R M Portillo, J F Kolhouse.   

Abstract

Human nasopharyngeal epidermoid carcinoma (KB) cells contain a membrane-associated particulate folate-binding protein which is important in the cellular accumulation of physiologic folates (Antony, A. C., Kane, M. A., Portillo, R. M., Elwood, P. C., and Kolhouse, J. F. (1985) J. Biol. Chem. 260, 14911-14917) and in the binding of methotrexate (Kane, M. A., Portillo, R. M., Elwood, P. C., Antony, A. C., and Kolhouse, J. F. (1986) J. Biol. Chem. 261, 44-49). A soluble folate-binding protein appears in media exposed to proliferating KB cells. We have purified to homogeneity both the membrane-associated and the soluble folate-binding proteins from the KB cell tissue culture system. The purified membrane-associated and soluble folate-binding proteins give single bands on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with apparent Mr values of 50,000 and 40,000, respectively. The membrane-associated folate-binding protein contains 45,000 g of amino acids and the soluble folate-binding protein contains 24,000 g of amino acids per mole of folate bound. Each of the purified proteins has a single folate-binding site, and the carbohydrate content is approximately 25% for each species of protein. The affinity constants for 5-methyltetrahydrofolate of the membrane-associated and soluble folate-binding proteins are 0.3 and 2.5 X 10(9) liters/mol, respectively. The affinities of various polyglutamated forms of methotrexate are similar for each protein, increase as the chain length of the polyglutamate increases (from approximately 0.004 X 10(9) liters/mol for methotrexate to 0.3 X 10(9) liters/mol for methotrexate heptaglutamate), are equal to the affinity for 5-methyltetrahydrofolate, and exceed the reported increase in affinity of methotrexate polyglutamates for dihydrofolate reductase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430957

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor.

Authors:  Antonio Quintana; Ewa Raczka; Lars Piehler; Inhan Lee; Andrzej Myc; Istvan Majoros; Anil K Patri; Thommey Thomas; James Mulé; James R Baker
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

2.  Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.

Authors:  C P Leamon; P S Low
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human cells.

Authors:  M A Kane; P C Elwood; R M Portillo; A C Antony; V Najfeld; A Finley; S Waxman; J F Kolhouse
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

4.  Complementation of a methotrexate uptake defect in Chinese hamster ovary cells by DNA-mediated gene transfer.

Authors:  T M Underhill; W F Flintoff
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

5.  Identification of high affinity folate binding proteins in human erythrocyte membranes.

Authors:  A C Antony; R S Kincade; R S Verma; S R Krishnan
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

6.  Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates.

Authors:  K N Chung; Y Saikawa; T H Paik; K H Dixon; T Mulligan; K H Cowan; P C Elwood
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Transfection of a glycosylated phosphatidylinositol-anchored folate-binding protein complementary DNA provides cells with the ability to survive in low folate medium.

Authors:  C A Luhrs; C A Raskin; R Durbin; B Wu; E Sadasivan; W McAllister; S P Rothenberg
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated.

Authors:  T Cihlár; I Rosenberg; I Votruba; A Holý
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Purified membrane and soluble folate binding proteins from cultured KB cells have similar amino acid compositions and molecular weights but differ in fatty acid acylation.

Authors:  C A Luhrs; P Pitiranggon; M da Costa; S P Rothenberg; B L Slomiany; L Brink; G I Tous; S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

10.  Functional folate receptor alpha is elevated in the blood of ovarian cancer patients.

Authors:  Eati Basal; Guiti Z Eghbali-Fatourechi; Kimberly R Kalli; Lynn C Hartmann; Karin M Goodman; Ellen L Goode; Barton A Kamen; Philip S Low; Keith L Knutson
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.